“CONSEQUENCES OBSERVED WHEN MEROPENEM IS ADMINISTERED TO PATIENTS WITH COVID-19” (2024) E Conference Zone, pp. 34–35. Available at: https://econferencezone.org/index.php/ecz/article/view/2743 (Accessed: 14 September 2025).